Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock?
Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD)
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
Third Harmonic Bio to Participate in Upcoming Investor Conferences
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. (THRD) is a Great Choice
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
Third Harmonic Bio Announces Leadership Changes
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Third Harmonic Bio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)
Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)
Why Is Third Harmonic Bio (THRD) Stock Down 75% Today?
Third Harmonic's stock falls 75% after discontinuing clinical trial
Third Harmonic Scores Most Successful Biotech IPO in Months
Is Third Harmonic Bio (THRD) Stock the Next Red-Hot IPO?
Third Harmonic Bio stock opens more than 20% above IPO price
TF Financial Corporation Shareholders Approve Merger with National Penn Bancshares, Inc.
National Penn Bancshares, Inc. Receives Regulatory Approvals for TF Financial Corporation Merger
INVESTOR ALERT – TF Financial Corporation: The Law Offices of Vincent Wong Investigates the Sale of TF Financial Corporation – THRD
Faruqi & Faruqi, LLP is Investigating TF Financial Corporation and its Board of Directors in Connection With the Proposed Sale of the Company to National Penn Bancshares
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of TF Financial Corporation In Connection With The Proposed Sale Of The Company To National Penn Bancshares
EQUITY ALERT: The Rosen Law Firm Announces Investigation of TF Financial Corporation (THRD) Concerning the Proposed Acquisition by National Penn Bancshares, Inc. (NPBC)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of TF Financial Corporation and Its Board of Directors In Connection With the Sale of the Company to National Penn Bancshares -- THRD
TF FINANCIAL CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of TF Financial Corporation and Its Board of Directors In Connection With the Sale of the Company to National Penn Bancshares
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of TF Financial Corporation In Connection With The Proposed Sale Of The Company To National Penn Bancshares
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of TF Financial Corporation Stockholders
TF FINANCIAL SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Sale of TF Financial to National Penn May be Unfair to Shareholders
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of TF Financial Corporation (THRD) Over the Proposed Sale of the Company to National Penn Bancshares (NPBC)